Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression (Major/Severe)
Location: United States, IL
Clinical Trial Details
Research Study Summary
A multicenter, randomized, double-blind study to evaluate the efficacy, safety and tolerability of an oral Aripiprazole-Escitalopram combination therapy in patients with Major Depressive Disorder.
This study is being done to find out the potential benefits and safety of taking two different study drugs at the same time. The study drugs are called Abilify(aripiprazole) and Lexapro(Escitalopram).
Please contact Alexian Brothers for more information on participation.
To Learn more
Both Male and Female
Date Last Changed:
July 22, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these